Article Details

$18.37 Million in Sales Expected for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) This Quarter

Retrieved on: 2021-02-06 06:33:45

Tags for this article:

Click the tags to see associated articles and topics

$18.37 Million in Sales Expected for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) This Quarter. View article details on hiswai:

Excerpt

The biotechnology company reported ($0.08) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.04. Rigel Pharmaceuticals ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo